Loading...
OTCM
CRLBF
Market cap172mUSD
Jun 12, Last price  
0.51USD
1D
-3.74%
1Q
-30.80%
IPO
-88.20%
Name

Cresco Labs Inc

Chart & Performance

D1W1MN
OTCM:CRLBF chart
P/E
P/S
0.24
EPS
Div Yield, %
Shrs. gr., 5y
23.90%
Rev. gr., 5y
41.31%
Revenues
724m
-6.04%
000000000003,157,23210,310,00043,252,000128,534,000476,251,000821,682,000842,681,000770,885,000724,343,000
Net income
-74m
L-57.59%
000000000047,37700-1,915,000-65,302,000-36,562,000-296,834,000-215,843,000-175,522,000-74,438,000
CFO
132m
+126.21%
000000034,8140083,507029,916-9,916,000-25,189,000-10,831,00014,487,00018,741,00058,564,000132,480,000
Earnings
Aug 06, 2025

Profile

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of December 6, 2022, it owned and operated 55 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.
IPO date
Dec 03, 2018
Employees
3,000
Domiciled in
US
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122018‑012017‑012016‑01
Income
Revenues
724,343
-6.04%
770,885
-8.52%
842,681
2.56%
Cost of revenue
592,161
486,100
506,228
Unusual Expense (Income)
NOPBT
132,182
284,785
336,453
NOPBT Margin
18.25%
36.94%
39.93%
Operating Taxes
49,873
32,950
88,938
Tax Rate
37.73%
11.57%
26.43%
NOPAT
82,309
251,835
247,515
Net income
(74,438)
-57.59%
(175,522)
-18.68%
(215,843)
-27.28%
Dividends
Dividend yield
Proceeds from repurchase of equity
(200)
3,088
BB yield
Debt
Debt current
23,557
21,233
44,936
Long-term debt
785,650
834,209
816,851
Deferred revenue
Other long-term liabilities
217,807
30,723
14,770
Net debt
671,643
751,283
741,218
Cash flow
Cash from operating activities
132,480
58,564
18,741
CAPEX
(19,492)
(55,385)
(86,132)
Cash from investing activities
(25,229)
(44,585)
(36,577)
Cash from financing activities
(71,478)
(26,907)
(86,643)
FCF
93,183
207,185
196,638
Balance
Cash
137,564
103,429
119,341
Long term investments
730
1,228
Excess cash
101,347
65,615
78,435
Stockholders' equity
265,426
345,537
587,683
Invested Capital
1,144,277
1,073,386
1,099,347
ROIC
7.42%
23.18%
21.42%
ROCE
10.29%
24.15%
26.85%
EV
Common stock shares outstanding
345,474
323,820
298,162
Price
Market cap
EV
EBITDA
198,175
354,089
394,178
EV/EBITDA
Interest
58,901
63,243
58,516
Interest/NOPBT
44.56%
22.21%
17.39%